• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Acadia Pharmaceutica (NQ: ACAD )

    14.81 +0.22 (+1.51%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Acadia Pharmaceutica

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Critical Insights From ACADIA Pharmaceuticals Analyst Ratings: What You Need To Know
    Via Benzinga
    What's Going On With ACADIA Pharmaceuticals Stock?
    ACADIA Pharmaceuticals shares are trading lower by 4.6% during Tuesday's session. The company appointed Catherine Owen Adams as CEO. 
    Via Benzinga
    Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
    Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&G Foods, Lucid, SoFi, Dell, Johnson & Johnson, UWM and Symbotic. 
    Via Benzinga
    Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
    Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations. 
    Via Investor's Business Daily
    Topics Earnings
    Exposures Financial
    Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Expert Outlook: ACADIA Pharmaceuticals Through The Eyes Of 5 Analysts
    Via Benzinga
    A Closer Look at 13 Analyst Recommendations For ACADIA Pharmaceuticals
    Via Benzinga
    Expert Ratings For ACADIA Pharmaceuticals
    Via Benzinga
    This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
    Via Benzinga
    3 Sorry Pharma Stocks to Sell in May While You Still Can
    Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks. 
    Via InvestorPlace
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
    Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. 
    Via Benzinga
    Topics Data Breach
    Exposures Information Security
    Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
    Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider. 
    Via InvestorPlace
    ACAD Stock Earnings: ACADIA Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
    ACAD stock results show that ACADIA Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
    Via Benzinga
    Expert Ratings For ACADIA Pharmaceuticals
    Via Benzinga
    ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings)
    Via Benzinga
    3 Pharma Stocks to Sell in April Before They Crash & Burn
    Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside. 
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    3 Pharma Stocks to Sell in March Before They Crash & Burn
    Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions. 
    Via InvestorPlace
    Why Are Airline Stocks Down Today?
    Airline stocks are down on Tuesday as investors deal with several bits of bad news for the industry on Tuesday! 
    Via InvestorPlace
    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. 
    Via Benzinga
    Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today?
    Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin. 
    Via InvestorPlace
    Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study
    The company says it doesn't plan to further develop Nuplazid in clinical testing. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday! 
    Via InvestorPlace
    Trial Setback For Acadia Pharmaceuticals' Late-Stage Schizophrenia Trial: Details
    Acadia Pharmaceuticals' Phase 3 ADVANCE-2 trial results on pimavanserin for schizophrenia-negative symptoms. Insights on efficacy, safety, and future considerations. 
    Via Benzinga
    ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.